Literature DB >> 12134991

Surgical treatment of hereditary lens subluxations.

Sengul Ozdek1, Ayca Sari, Kamil Bilgihan, Fikret Akata, Berati Hasanreisoglu.   

Abstract

BACKGROUND AND
OBJECTIVE: To evaluate the effectiveness and results of pars plana vitreolensectomy approach with transscleral fixation of intraocular lens in hereditary lens subluxations.
METHODS: Fifteen eyes of 9 consecutive patients with a mean age of 12.8+/-6.2 years (6-26 years) with hereditary lens subluxation were operated on and the results were evaluated in a prospective study. Surgery was considered if best spectacle corrected visual acuity (BSCVA) was less than 20/70. All eyes underwent a 2-port pars plana vitreolensectomy and transscleral fixation of an intraocular lens (IOL).
RESULTS: The mean follow-up period was 12.6+/-7.5 months (6-22 months). There was no major intraoperative complication. Preoperatively, 8 eyes (53.3%) had a BSCVA of counting fingers (CF) and 7 eyes (46.6%) had a BSCVA of 20/200 to 20/70. Postoperatively, 14 eyes (93.3%) had a BSCVA of 20/50 or better. None of the patients had IOL decentration or intraocular pressure (IOP) increase during the follow-up period. There was a macular hole formation in 1 eye postoperatively.
CONCLUSIONS: The early results of pars plana vitreolensectomy with IOL implantation using scleral fixation technique had shown that it not only promises a rapid visual rehabilitation but it is also a relatively safe method. More serious complications, however, may occur in the long term.

Entities:  

Mesh:

Year:  2002        PMID: 12134991

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  2 in total

1.  Visual outcome and complications in Ab-externo scleral fixation IOL in aphakia in pediatric age group.

Authors:  Isra Ahmed Bhutto; Ghulam Qadir Kazi; P S Mahar; Umair Ahmed Qidwai
Journal:  Pak J Med Sci       Date:  2013-07       Impact factor: 1.088

2.  How far is observation allowed in patients with ectopia lentis?

Authors:  Toshihiko Matsuo
Journal:  Springerplus       Date:  2015-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.